{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:39:05Z","timestamp":1770817145915,"version":"3.50.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/ico.0b013e318265684b","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T12:15:35Z","timestamp":1349007335000},"page":"579-582","source":"Crossref","is-referenced-by-count":15,"title":["Comparative Evaluation of Topical Pranoprofen and Fluorometholone in Cases With Chronic Allergic Conjunctivitis"],"prefix":"10.1097","volume":"32","author":[{"given":"Zhiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoying","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lufang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Jhanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-11-20210204","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1358\/dot.1998.34.11.487480","article-title":"Ocular allergic disease.","volume":"34","author":"Bhargava","year":"1998","journal-title":"Drugs Today (Barc)"},{"key":"R3-11-20210204","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/187221311794474883","article-title":". Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.","volume":"5","author":"Mishra","year":"2011","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"R4-11-20210204","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.revmed.2011.01.003","article-title":"Ophthalmologic adverse effects of systemic corticosteroids in French.","volume":"32","author":"Lebreton","year":"2011","journal-title":"Rev Med Interne"},{"key":"R5-11-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks.","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"key":"R6-11-20210204","first-page":"237","article-title":"Efficacy of local conjunctival immunotherapy in allergic conjunctivitis.","volume":"28","author":"Kasetsuwan","year":"2010","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R7-11-20210204","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/jop.2008.0121","article-title":". Comparison of efficacy of bromfenac sodium 0.1 ophthalmic solution and fluorometholone 0.02 ophthalmic suspension for the treatment of allergic conjunctivitis.","volume":"25","author":"Fujishima","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"R8-11-20210204","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9394(14)70073-X","article-title":"Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen Study Group.","volume":"117","author":"Notivol","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"R9-11-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1185\/030079903125001794","article-title":". Topical azelastine in perennial allergic conjunctivitis.","volume":"19","author":"Canonica","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"R10-11-20210204","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1210\/endo.139.5.5961","article-title":". Regulation of cyclooxygenase-2 and prostaglandin F synthase gene expression by steroid hormones and interferon-tau in bovine endometrial cells.","volume":"139","author":"Xiao","year":"1998","journal-title":"Endocrinology"},{"key":"R11-11-20210204","first-page":"60","article-title":". Mechanism of action of an anti-inflammatory steroid on changes in vascular permeability (II). Evaluation of its action as a phospholipase A2 inhibitor in Japanese.","volume":"13","author":"Tajima","year":"1984","journal-title":"Josai Shika Daigaku Kiyo"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e318265684b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:34:23Z","timestamp":1621884863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201305000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318265684b","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}